MENS

Jyong Biotech
MENS

8 hedge funds and large institutions have $4.15M invested in Jyong Biotech in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.12M
2
+$512K
3
+$113K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$66.9K
5
UBS Group
UBS Group
Switzerland
+$21.1K

Top Sellers

1
-$2.3M
2
-$82.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$2.12M
HF
2
HRT Financial
New York
$819K
Millennium Management
3
Millennium Management
New York
$512K
Citadel Advisors
4
Citadel Advisors
Florida
$498K
Morgan Stanley
5
Morgan Stanley
New York
$113K
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$66.9K
UBS Group
7
UBS Group
Switzerland
$21.1K
TRCT
8
Tower Research Capital (TRC)
New York
$1.02K